Assessment of the Role of Urinary Heparanase in Lupus Nephritis Patients and Its Correlation with Disease Activity
Open Access
- 1 January 2022
- journal article
- research article
- Published by Medknow in Saudi Journal of Kidney Diseases and Transplantation
- Vol. 33 (6) , 746-754
Abstract
Assessing the activity of lupus nephritis (LN) with novel biomarkers is a promising noninvasive diagnostic tool for managing systemic lupus erythematosus (SLE). We assessed the ability of urinary heparanase to identify LN and its relation to the disease's activity. This crosssectional study had 90 subjects: 70 patients with SLE and 20 healthy controls. A full medical history, clinical examination, and routine investigations were carried out for the patients and controls. Immunological assays and assessments of the disease's activity with the SLE Disease Activity Index (SLEDAI) and the renal SLEDAI (r-SLEDAI) were carried out for LN groups. Urinary heparanase levels were measured using an enzyme-linked immunosorbent assay for all subjects. Of our patients, 20 had active LN, 17 had nonactive LN, 18 had active lupus without renal involvement, and 15 had nonactive lupus without renal involvement. The level of urinary heparanase was significantly higher in the LN groups than in the non-LN groups and the controls and was significantly higher in those with active LN than in those with nonactive LN. There were significant positive correlations between urinary heparanase and 24-h urinary protein, total SLEDAI, and r-SLEDAI, and significant negative correlations between urinary heparanase and Complements 3 and 4. Urinary heparanase predicted the activity of LN with a sensitivity of 80% and a specificity of 91.43%. Urinary heparanase levels were higher in patients with active LN and correlated with the markers of disease activity, indicating that it can serve as a useful new biomarker for the activity of LN.Keywords
This publication has 21 references indexed in Scilit:
- Biomarkers in systemic lupus erythematosus: challenges and prospects for the futureTherapeutic Advances in Musculoskeletal Disease, 2013
- Elevated Urine Heparanase Levels Are Associated with Proteinuria and Decreased Renal Allograft FunctionPLOS ONE, 2012
- Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?Lupus, 2011
- Heparanase Levels Are Elevated in the Urine and Plasma of Type 2 Diabetes Patients and Associate with Blood Glucose LevelsPLOS ONE, 2011
- Biomarkers for Lupus Nephritis: A Critical AppraisalJournal of Biomedicine and Biotechnology, 2010
- Biomarkers of lupus nephritis determined by serial urine proteomicsKidney International, 2008
- Urinary lipocalin‐2 is associated with renal disease activity in human lupus nephritisArthritis & Rheumatism, 2007
- Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indicesBest Practice & Research Clinical Rheumatology, 2005
- Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritisArthritis & Rheumatism, 2004
- Heparanase Is Involved in the Pathogenesis of Proteinuria as a Result of GlomerulonephritisJournal of the American Society of Nephrology, 2004